Patents Assigned to ABVIRIS DEUTSCHLAND GMBH
  • Serologic test for therapy control of HPV16 positive carcinoma
    Patent number: 11506667
    Abstract: A method for therapy control of HPV16 positive carcinoma, an antibody for use in the corresponding diagnostic method as well as a test for performing the method. In particular, a serologic method for monitoring the development of the amount of antibodies in samples, which were taken from a patient before and after the treatment of a HPV16 positive carcinoma over a predetermined period of time. In addition, an immunologic test in the form of a kit, with which the method can be performed.
    Type: Grant
    Filed: September 9, 2020
    Date of Patent: November 22, 2022
    Assignee: Abviris Deutschland GmbH
    Inventor: Ralf Hilfrich
  • Serologic test for therapy control of HPV16 positive carcinoma
    Patent number: 10852303
    Abstract: A method for therapy control of HPV16 positive carcinoma, an antibody for use in the corresponding diagnostic method as well as a test for performing the method. In particular, a serologic method for monitoring the development of the amount of antibodies in samples, which were taken from a patient before and after the treatment of a HPV16 positive carcinoma over a predetermined period of time. In addition, an immunologic test in the form of a kit, with which the method can be performed.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: December 1, 2020
    Assignee: ABVIRIS DEUTSCHLAND GMBH
    Inventor: Ralf Hilfrich
  • Rapid test for the qualitative and/or quantitative analysis of antibodies against human papilloma viruses (HPV) present in body fluid, and device for carrying out the rapid test
    Patent number: 10605809
    Abstract: A rapid test for a qualitative and/or quantitative assay of antibodies present in body fluid against human papilloma viruses (HPV) includes mixing a specimen of body fluid with a reagent which essentially comprises a predetermined quantity of physiologically acting liquid and a predetermined quantity of at least one HPV-specific antigen. The mixture is fed to an analysis which utilizes a change that is at least one of measurable or perceivable by a user.
    Type: Grant
    Filed: May 22, 2018
    Date of Patent: March 31, 2020
    Assignee: ABVIRIS DEUTSCHLAND GMBH
    Inventor: Ralf Hilfrich
  • Rapid test for the qualitative and/or quantitative analysis of antibodies against human papilloma viruses (HPV) present in body fluid, and device for carrying out the rapid test
    Patent number: 10006914
    Abstract: A rapid test for a qualitative and/or quantitative assay of antibodies present in body fluid against human papilloma viruses (HPV) includes mixing a specimen of body fluid with a reagent which essentially comprises a predetermined quantity of physiologically acting liquid and a predetermined quantity of at least one HPV-specific antigen. The mixture is fed to an analysis which utilizes a change that is at least one of measurable or perceivable by a user.
    Type: Grant
    Filed: November 28, 2016
    Date of Patent: June 26, 2018
    Assignee: ABVIRIS DEUTSCHLAND GMBH
    Inventor: Ralf Hilfrich